Medgend Icon

Ledgend of Medicine







discontinued


Omeprazole FDA Approved Drugs

ESOMEPRAZOLE MAGNESIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
RX
-
eq 20mg base (oral capsule, delayed rel pellets)
eq 40mg base (oral capsule, delayed rel pellets)
Aurobindo Pharma LtdApr 21, 2016
Dr Reddys Labs LtdSep 25, 2015
Hetero Labs Ltd IiiSep 21, 2015
Ivax Sub Teva PharmsJan 26, 2015
Mylan Pharms IncAug 2, 2015
Torrent Pharms LtdOct 19, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESOMEPRAZOLE SODIUM [Esomeprazole SodiumC17H18N3O3SNa]
RX
-
eq 20mg base/vial (intravenous injectable)
eq 40mg base/vial (intravenous injectable)
Aurobindo Pharma LtdAug 10, 2016
Mylan Labs LtdMay 17, 2017
Sun Pharma GlobalMar 18, 2013
Accord HlthcareSep 25, 2015
Deva Holding AsMar 6, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESOMEPRAZOLE STRONTIUM [Esomeprazole Strontium2C17H18N3O3SSr4H2O]
RX
-
24.65mg (oral capsule, delayed release)
49.3mg (oral capsule, delayed release)
R2 Pharma LlcAug 6, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NAPROXEN AND ESOMEPRAZOLE MAGNESIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
-
eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Dr Reddys Labs LtdSep 27, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NEXIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
RX
-
eq 10mg base/packet (oral for suspension, delayed release)
eq 2.5mg base/packet (oral for suspension, delayed release)
eq 20mg base (oral capsule, delayed rel pellets)
eq 20mg base/packet (oral for suspension, delayed release)
eq 40mg base (oral capsule, delayed rel pellets)
eq 40mg base/packet (oral for suspension, delayed release)
eq 5mg base/packet (oral for suspension, delayed release)
Astrazeneca PharmsFeb 27, 2008
  • Pediatric use aged 1-11 years, gerd and erosive esophagitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NEXIUM 24HR [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
Astrazeneca LpMar 28, 2014
  • Treatment of frequent heartburn by administering a gastric acid reducer.
  • Treatment of frequent heartburn by administering omeprazole according to claims 1-8.
  • Treatment of frequent heartburn by administering s-omeprazole trihydrate according to claims 1-3.
efficacy
4.5  (11)
side effects
1.1  (11)
danger
1.0  (10)

UNK

OMEPRAZOLE [OmeprazoleC17H19N3O3S]
RX / OTC
-
10mg (oral capsule, delayed rel pellets)
20mg (oral capsule, delayed rel pellets)
40mg (oral capsule, delayed rel pellets)
Actavis Labs Fl IncMay 30, 2008
ApotexOct 22, 2007
Aurobindo Pharma LtdAug 19, 2015
Breckenridge PharmJul 3, 2017
Dr Reddys Labs LtdMar 16, 2009
Glenmark GenericsOct 31, 2014
Impax LabsOct 22, 2007
Kremers Urban PharmsNov 1, 2002
MylanMay 29, 2003
SandozJan 28, 2003
Zydus Pharms Usa IncNov 19, 2012
Dexcel PharmaDec 4, 2007
Teva Pharms UsaJun 13, 2017
Lupin LtdAug 25, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN [AmoxicillinC16H19N3O5S3H2O : ClarithromycinC38H69NO13 : OmeprazoleC17H19N3O3S]
RX
-
500mg,n/a,n/a : n/a,500mg,n/a : n/a,n/a,20mg (oral capsule, tablet, capsule, delayed release)
GastroenteroFeb 8, 2011
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OMEPRAZOLE AND SODIUM BICARBONATE [OmeprazoleC17H19N3O3S : Sodium BicarbonateCHO3Na]
RX / OTC
-
20mg/packet : 1.68gm/packet (oral for suspension)
20mg : 1.1gm (oral capsule)
40mg/packet : 1.68gm/packet (oral for suspension)
40mg : 1.1gm (oral capsule)
Ajanta Pharma LtdJul 27, 2016
Par PharmApr 19, 2013
Actavis ElizabethJul 15, 2016
Aurolife Pharma LlcAug 19, 2016
Dr Reddys Labs LtdJul 15, 2016
Perrigo R And DJul 15, 2016
Sciegen Pharms IncDec 6, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OMEPRAZOLE MAGNESIUM [Omeprazole Magnesium2C17H18N3O3SMg]
OTC
-
eq 20mg base (oral capsule, delayed release)
Dr Reddys Labs LtdJun 5, 2009
Perrigo R And DJul 30, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PRILOSEC [Omeprazole Magnesium2C17H18N3O3SMg]
RX
-
eq 10mg base/packet (oral for suspension, delayed release)
eq 2.5mg base/packet (oral for suspension, delayed release)
Covis Pharma BvMar 20, 2008
  • Pediatric use ages 1 month to 2 years, gerd and erosive esophagitis.
  • Pediatric use ages 1-2 years, gerd and erosive esophagitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PRILOSEC OTC [Omeprazole Magnesium2C17H18N3O3SMg]
OTC
-
eq 20mg base (oral tablet, delayed release)
Astrazeneca PharmsJun 20, 2003
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

PYLERA [Bismuth Subcitrate Potassium2C6H4O7Bi5K3H2O : MetronidazoleC6H9N3O3 : TetracyclineC22H24N2O8]
RX
-
140mg : 125mg : 125mg (oral capsule)
Forest Labs LlcSep 28, 2006
  • Pylera capsules, in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease to eradicate h. pylori.
  • Treatment of patients with h. pylori infection and duodenal ulcer disease.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIMOVO [Esomeprazole Magnesium2C17H18N3O3SMg3H2O : NaproxenC14H14O3]
RX
-
eq 20mg base : 375mg (oral tablet, delayed release)
eq 20mg base : 500mg (oral tablet, delayed release)
Horizon Pharma UsaApr 30, 2010
  • Relief of signs and symptoms of arthritis and risk-reduction of nsaid-associated gastric ulcer.
  • Risk-reduction of nsaid gastric ulcer in patients requiring chronic nsaid treatment.
  • Risk-reduction of nsaid-associated gastric ulcer in patients requiring nsaid treatment.
  • Risk-reduction of nsaid-associated gastric ulcer.
  • Risk-reduction of nsaid-associated gastric ulcers in patients also taking low dose aspirin.
efficacy
3.5  (2)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.